Abetalipoproteinemia: A Patient Guide
At a Glance
Abetalipoproteinemia is a rare inherited condition caused by an MTTP gene change that limits absorption and transport of dietary fat and vitamins A, D, E, and K. Lifelong supervised dietary planning, high-dose vitamins, and specialist monitoring can reduce neurological and vision complications.
Abetalipoproteinemia (ABL) is an exceptionally rare genetic condition that fundamentally changes how your body interacts with the food you eat. At its core, the condition is a “shipping failure” within your cells. Due to a mutation in the MTTP gene, your body has a severely impaired ability to produce a vital protein needed to package fats and essential vitamins into transport containers called lipoproteins. Without enough of these containers, dietary fats and critical fat-soluble vitamins—A, D, E, and K—are markedly reduced in absorption and transport, remaining largely in your intestinal cells and liver instead of entering your bloodstream to nourish your nerves, eyes, and organs [1][2].
Key Safety Point: Vitamin and dietary treatments for ABL require careful medical supervision. Do not start, stop, or change your high-dose vitamin supplements or diet on your own, as these vitamins can be toxic at high levels and require clinical monitoring.
This internal transport failure usually reveals itself early in life, often beginning in infancy with digestive distress. Because the body cannot effectively absorb fat, it reacts with symptoms like oily stools and difficulty gaining weight. If left unmanaged, the chronic lack of vitamins—particularly vitamin E—begins to affect the nervous system and the eyes over time. This can lead to challenges with balance and coordination, as well as gradual changes in vision. These symptoms represent the body’s signal that it is missing the essential nutrients required to maintain the health of its most delicate tissues [3][4].
Living with ABL requires a lifelong commitment to a specialized treatment strategy designed to bypass this biological bottleneck. The foundation of care involves an individualized low-long-chain-fat plan to prevent digestive complications, paired with specialized, supervised high doses of oral fat-soluble vitamins. Because your body absorbs only a tiny fraction of these supplements, the doses must be far higher than standard recommendations to ensure enough nutrients reach your system. When this regimen is started early and maintained consistently, many of the most serious neurological and visual complications can be stabilized, significantly delayed, or even prevented [5][6].
Because ABL affects multiple parts of the body, the most effective way to manage it is through a multidisciplinary care team. This team typically includes specialists in metabolism, nutrition, neurology, and ophthalmology, all working together to monitor your health and adjust your treatment as you grow. While the diagnosis is life-changing and the management is intensive, staying connected with experienced providers allows you to take a proactive role in your health. With modern management and careful monitoring, it is possible to navigate the challenges of ABL and lead a full, active life [7][8].
In this guide
6 chapters
Understanding Your Journey with Abetalipoproteinemia (ABL)
Learn how abetalipoproteinemia (ABL) affects fat and vitamin absorption, causes symptoms, and is managed with diet, supplements, monitoring, and specialist care.
Recognizing and Monitoring Symptoms of Abetalipoproteinemia (ABL)
Learn to recognize abetalipoproteinemia symptoms, monitor vitamin deficiencies, and know when digestive, vision, balance, or bleeding changes need urgent care.
The Biology of Abetalipoproteinemia: A "Shipping" Failure
Learn how MTTP mutations cause abetalipoproteinemia, impair fat transport, lead to vitamins A, D, E, and K deficiency, and distinguish it from similar disorders.
Diagnosing ABL: Understanding Your Lab Results
Learn how abetalipoproteinemia is diagnosed using very low LDL and apoB, vitamin levels, blood smear findings, PT/INR, liver tests, and MTTP genetic testing.
Managing Abetalipoproteinemia: Standard of Care Treatment
Learn how abetalipoproteinemia treatment combines a low-long-chain-fat diet, MCT oil, and supervised vitamins A, D, E, and K, plus careful safety monitoring.
Staying Healthy Long-Term: Monitoring and Survivorship
Learn how long-term abetalipoproteinemia monitoring supports vision, liver, nerves, bones, and emotional health through coordinated adult care and regular tests.
Common questions in this guide
What causes abetalipoproteinemia?
What symptoms can abetalipoproteinemia cause?
Why does abetalipoproteinemia require high-dose vitamins?
What diet is used to manage abetalipoproteinemia?
Can treatment prevent nerve and vision problems from abetalipoproteinemia?
Which specialists treat abetalipoproteinemia?
Get notified when new evidence is published on Abetalipoproteinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, et al.
Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.
PMID: 33994405 - 2
Lipid transfer proteins in the assembly of apoB-containing lipoproteins.
Sirwi A, Hussain MM
Journal of lipid research 2018; (59(7)):1094-1102 doi:10.1194/jlr.R083451.
PMID: 29650752 - 3
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.
Le R, Zhao L, Hegele RA
Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.
PMID: 35221233 - 4
A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.
Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.
Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.
PMID: 33258201 - 5
Abetalipoproteinemia Due to a Novel Splicing Variant in MTTP in 3 Siblings.
Vlasschaert C, McIntyre AD, Thomson LA, et al.
Journal of investigative medicine high impact case reports 2021; (9()):23247096211022484 doi:10.1177/23247096211022484.
PMID: 34078172 - 6
Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
Triantafillidis JK, Manioti A, Pittaras T, et al.
Journal of personalized medicine 2025; (15(8)) doi:10.3390/jpm15080354.
PMID: 40863416 - 7
Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?
Sissaoui S, Cochet M, Poinsot P, et al.
Journal of pediatric gastroenterology and nutrition 2021; (73(1)):4-8 doi:10.1097/MPG.0000000000003145.
PMID: 33853111 - 8
A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.
Valmiki S, Bredefeld C, Hussain MM
Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.
PMID: 39672332
This page is for educational purposes only and does not constitute medical advice. Because high-dose vitamins and dietary changes for abetalipoproteinemia require careful monitoring, consult your metabolic and nutrition specialists before changing treatment.